Vaxxinity, Inc. VAXX
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -56.93M | -66.00M | -72.11M | -- | -- |
| Total Depreciation and Amortization | 2.23M | 2.32M | 2.07M | -- | -- |
| Total Amortization of Deferred Charges | 51.00K | 52.00K | 52.00K | -- | -- |
| Total Other Non-Cash Items | 5.95M | 7.00M | 7.52M | -- | -- |
| Change in Net Operating Assets | -8.54M | -3.24M | 4.38M | -- | -- |
| Cash from Operations | -57.24M | -59.87M | -58.09M | -- | -- |
| Capital Expenditure | -803.00K | -681.00K | -876.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.65M | 57.14M | -16.91M | -- | -- |
| Cash from Investing | 28.84M | 56.46M | -17.79M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.59M | -1.39M | -1.06M | -- | -- |
| Issuance of Common Stock | 454.00K | 454.00K | 427.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -- | -- |
| Cash from Financing | -1.14M | -936.00K | -635.00K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.53M | -4.35M | -76.51M | -- | -- |